Lithuania's population-based cancer registry, kept by the National Cancer Institute in Vilnius. It holds records of new cancers diagnosed in Lithuania since 1978, receives more than 25,000 notifications a year, and opened a public data portal in 2025.
The Cancer Registry (Vėžio registras) is a population-based registry covering the whole of Lithuania. Its page on the National Cancer Institute's site states that it was established by Government resolution No. 806 of 11 August 2016, which approved its regulations, and began work under them on 1 January 2017; the regulations of its information system were approved in July 2025, with the Ministry of Health as controller and the National Cancer Institute as the registry's keeper. The coordinates are those of the institute, approximately.
Doctors who diagnose a cancer notify it on statistical form No. 090/a; notifications also arrive electronically and as pathology files, and from 1 January 2026 data are received from the national e-health system (ESPBI IS). The page counts more than 25,000 notifications a year and more than 500,000 since 1978, and cross-checks against death certificates and the State Register of Deaths and their Causes. Diagnoses are coded in ICD-10-AM and ICD-O-3.1, with tumour grade recorded since 2003 and TNM 8th edition stage since 2020. The registry is a member of the International Association of Cancer Registries and the European Network of Cancer Registries, has sent data to Cancer Incidence in Five Continents since 1998, and contributes to CONCORD, EUROCARE and the International Incidence of Childhood Cancer.
The institute's activity report for 2025 gives the registry's headline figures: 16,413 new cancers registered in 2022, an age-standardised rate of 287.9 per 100,000, about 138,500 people living after a cancer diagnosis in 2022, and five-year survival of 59% for men and 69% for women. Since 2025 an open data portal, registras.nvi.lt, shows incidence, prevalence, survival and mortality in interactive tables.
Lithuanian radiotherapy machines are modern and heavily used, but there are too few of them for the number of patients who could benefit.
Lithuania has offered PSA testing through a national programme since 2006; this is an account, from the National Cancer Institute's cancer epidemiology laboratory, of what the programme did in its first decade.
In its first years the programme did not by itself shift breast cancers to earlier stages; awareness and better diagnosis may explain the trends.
Shares Radiotherapy and diagnostic capacity in Estonia, Latvia and Lithuania, National Cancer Institute, Lithuania, Ministry of Health of the Republic of Lithuania.
Shares Cancer registries and population surveillance, International Agency for Research on Cancer (IARC / WHO), Breast cancer (all types), Prostate cancer.
Shares Cancer registries and population surveillance, International Agency for Research on Cancer (IARC / WHO), Breast cancer (all types), Prostate cancer.
Shares Ministry of Health of the Republic of Lithuania, Breast cancer (all types), Prostate cancer.
Shares Cancer registries and population surveillance, International Agency for Research on Cancer (IARC / WHO), Breast cancer (all types), Prostate cancer.
Shares Cancer registries and population surveillance, International Agency for Research on Cancer (IARC / WHO), Breast cancer (all types), Prostate cancer.
Shares Cancer registries and population surveillance, International Agency for Research on Cancer (IARC / WHO), Breast cancer (all types), Prostate cancer.
Shares Cancer registries and population surveillance, International Agency for Research on Cancer (IARC / WHO), Breast cancer (all types), Prostate cancer.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/